Voloridge Investment Management
COGT icon

Voloridge Investment Management’s Cogent Biosciences COGT Stock Holding History

Voloridge Investment Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-668,970
Closed -$23.8M – 1054
2025
Q4 		$23.8M Buy
+668,970
New +$18.8M 0.08% 314
2025
Q2 		– Sell
-66,930
Closed -$401K – 1192
2025
Q1 		$401K Buy
+66,930
New +$525K ﹤0.01% 1106
2022
Q4 		– Sell
-288,567
Closed -$4.3M – 1463
2022
Q3 		$4.3M Buy
+288,567
New +$3.96M 0.02% 701

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Voloridge Investment Management's COGT Position: Q1 2026 in Review

Voloridge Investment Management sold out of Cogent Biosciences (COGT) in Q1 2026, closing a stake of 668,970 shares — an estimated $23.8M sold.

Voloridge Investment Management first reported a position in COGT in Q3 2022 and held it in 3 quarters. The position peaked at $23.8M in Q4 2025. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Voloridge Investment Management reported no remaining Cogent Biosciences position as of Q1 2026 after selling out during the quarter.
  • Voloridge Investment Management sold 668,970 Cogent Biosciences shares in Q1 2026, an estimated $23.8M.
  • Voloridge Investment Management first reported a position in Cogent Biosciences in Q3 2022 and held it in 3 quarters.
  • Voloridge Investment Management's Cogent Biosciences position peaked at $23.8M in Q4 2025.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.